arctigenin has been researched along with Inflammation in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 7 (43.75) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, C; Feng, C; Li, H; Liu, M; Lu, H; Qi, Q; Su, H; Tang, W; Xiang, C; Xu, Y; Zhang, X; Zhou, Y | 1 |
| Guo, R; Ji, Z; Li, H; Ma, Z | 1 |
| Dong, X; Li, S; Lou, Z; Wang, D; Wang, G; Wu, Y; Yuan, Q; Zhou, X | 1 |
| Huang, YS; Li, H; Li, Y; Lu, L; Ni, SH; Sun, SN; Wang, JJ; Wang, LJ; Xian, SX; Xiao, W; Yang, ZQ; Zhou, Z | 1 |
| Huang, H; Liu, H; Shang, P; Tang, Q; Tang, S; Xu, J; Yang, S; Zhang, J; Zheng, X; Zhong, X; Zhou, W | 1 |
| Deng, Y; Jiang, L; Li, W; Lu, Y | 1 |
| Chen, F; Huang, Q; Jiang, H; Liu, J; Long, F; Lv, L; Qin, T; Ren, L; Xie, Y; Zeng, M | 1 |
| Alaj, R; Beretta, G; Cavolli, R; Daci, A; Krasniqi, S; Neziri, B; Norata, GD | 1 |
| Chen, JT; Chen, KY; Chen, YP; Ho, BY; Hsieh, MC; Hsu, AC; Hsu, RY; Lin, JA; Shen, TL; Tai, YT; Wang, GH; Wu, HT; Yao, HY | 1 |
| Cheng, X; Cheng, Y; Da, Y; Li, Y; Wang, D; Wang, H; Wang, Y; Xue, Z; Yang, F; Yang, J; Yang, L; Zhang, L; Zhang, Q; Zhang, R; Zhou, D | 1 |
| Ding, CG; Ding, XM; Dou, M; Han, F; Tian, PX; Wang, YX; Xia, XX; Xue, WJ; Zheng, J | 1 |
| Dai, J; Dong, G; Fang, R; Li, C; Li, Z; Ma, Q; Ming, J; Ning, Z; Shi, H; Si, C; Xiong, H; Yan, F; Zhang, H; Zhang, J | 1 |
| Bai, G; Cheng, BF; Dong, LY; Hou, YY; Jiang, M; Zhao, ZY | 1 |
| Li, A; Pan, R; Wang, J; Wang, R; Zhang, X; Zhu, D | 1 |
| Kim, CJ; Lee, JY | 1 |
| Fan, T; Feng Zhang, Y; Jiang, WL; Zhu, J | 1 |
16 other study(ies) available for arctigenin and Inflammation
| Article | Year |
|---|---|
Identification of phosphodiesterase-4 as the therapeutic target of arctigenin in alleviating psoriatic skin inflammation.
Topics: Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Furans; Humans; Inflammation; Leukocytes, Mononuclear; Lignans; Mice | 2021 |
Arctigenin inhibits apoptosis, extracellular matrix degradation, and inflammation in human nucleus pulposus cells by up-regulating miR-483-3p.
Topics: Apoptosis; Cells, Cultured; Extracellular Matrix; Extracellular Matrix Proteins; Furans; Humans; Inflammation; Intervertebral Disc Degeneration; Lignans; MicroRNAs; NF-kappa B; Nucleus Pulposus | 2022 |
Preventive effects of arctigenin from Arctium lappa L against LPS-induced neuroinflammation and cognitive impairments in mice.
Topics: Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Arctium; Aspartic Acid Endopeptidases; Cognitive Dysfunction; Furans; Inflammation; Lignans; Lipopolysaccharides; Memory Disorders; Mice; Microglia; Neuroinflammatory Diseases; NF-kappa B; Toll-Like Receptor 4 | 2022 |
Arctigenin alleviates myocardial infarction injury through inhibition of the NFAT5-related inflammatory phenotype of cardiac macrophages/monocytes in mice.
Topics: Animals; Furans; Heart; Inflammation; Lignans; Macrophages; Male; Mice; Mice, Inbred C57BL; Monocytes; Myocardial Infarction; Myocardium; RAW 264.7 Cells; Signal Transduction; Transcription Factors | 2020 |
Arctigenin prevents the progression of osteoarthritis by targeting PI3K/Akt/NF-κB axis: In vitro and in vivo studies.
Topics: Animals; Cartilage, Articular; Chondrocytes; Dinoprostone; Disease Models, Animal; Disease Progression; Furans; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Lignans; Mice; Molecular Docking Simulation; NF-kappa B; Nitric Oxide Synthase Type II; Nitrous Oxide; Osteoarthritis; Phosphatidylinositol 3-Kinases; Primary Cell Culture; Proto-Oncogene Proteins c-akt; Signal Transduction | 2020 |
Arctigenin suppresses fibroblast activity and extracellular matrix deposition in hypertrophic scarring by reducing inflammation and oxidative stress.
Topics: Animals; Antioxidants; Bleomycin; Cicatrix, Hypertrophic; Cytokines; Disease Models, Animal; Extracellular Matrix; Female; Fibroblasts; Fibrosis; Furans; Inflammation; Lignans; Malondialdehyde; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Oxidative Stress; Pulmonary Fibrosis; Superoxide Dismutase; Transforming Growth Factor beta1 | 2020 |
Targeting Tristetraprolin Expression or Functional Activity Regulates Inflammatory Response Induced by MSU Crystals.
Topics: Animals; Anti-Inflammatory Agents; Autophagy; Caspase 1; Cell Culture Techniques; Cytokines; Furans; Inflammation; Lignans; Lysosomes; Mice; Mice, Inbred C57BL; Mitochondria; Protein Phosphatase 2; Reactive Oxygen Species; RNA, Small Interfering; Tristetraprolin; Uric Acid | 2021 |
Arctigenin improves vascular tone and decreases inflammation in human saphenous vein.
Topics: Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Furans; Humans; Inflammation; Inflammation Mediators; Lignans; Saphenous Vein; Vascular Resistance; Vasodilation | 2017 |
Arctigenin protects against steatosis in WRL68 hepatocytes through activation of phosphoinositide 3-kinase/protein kinase B and AMP-activated protein kinase pathways.
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Arctium; Carnitine O-Palmitoyltransferase; Fatty Liver; Furans; Hep G2 Cells; Hepatocytes; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interleukins; Lignans; Liver; Non-alcoholic Fatty Liver Disease; Oleic Acid; Oxidative Stress; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phytotherapy; Plant Extracts; PPAR alpha; Proto-Oncogene Proteins c-akt; Signal Transduction; Sterol Regulatory Element Binding Protein 1 | 2018 |
Arctigenin protects against liver injury from acute hepatitis by suppressing immune cells in mice.
Topics: Acute Disease; Animals; CD4-Positive T-Lymphocytes; Concanavalin A; Furans; Hepatitis; Inflammation; Inflammation Mediators; Interleukin-10; Lignans; Liver; Macrophages; Male; Mice; Mice, Inbred BALB C; Natural Killer T-Cells; Protective Agents; RAW 264.7 Cells | 2018 |
Arctigenin: A two-edged sword in ischemia/reperfusion induced acute kidney injury.
Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Apoptosis; Disease Models, Animal; Dose-Response Relationship, Drug; Furans; Inflammation; Kidney; Lignans; Male; Mice, Inbred C57BL; Oxidative Stress; Reperfusion Injury | 2018 |
Arctigenin Ameliorates Inflammation by Regulating Accumulation and Functional Activity of MDSCs in Endotoxin Shock.
Topics: Animals; Arginase; Furans; Inflammation; Interferon Regulatory Factors; Lignans; Lipopolysaccharides; Mice; MicroRNAs; Myeloid-Derived Suppressor Cells; Nitric Oxide Synthase Type II; RNA, Messenger; Shock, Septic | 2018 |
[Anti-inflammatory mechanism of qingfei xiaoyan wan studied with network pharmacology].
Topics: Animals; Anti-Inflammatory Agents; Asthma; Cell Line; Cholic Acid; Coumaric Acids; Cytokines; Drug Combinations; Drugs, Chinese Herbal; Epithelial Cells; Female; Furans; Guinea Pigs; Humans; Inflammation; Lignans; Lung; Male; MAP Kinase Signaling System; Random Allocation; Receptors, IgE; Toll-Like Receptors | 2013 |
Arctigenin suppresses transforming growth factor-β1-induced expression of monocyte chemoattractant protein-1 and the subsequent epithelial-mesenchymal transition through reactive oxygen species-dependent ERK/NF-κB signaling pathway in renal tubular epithe
Topics: Antigens, CD; Antioxidants; Cadherins; Cell Movement; Chemokine CCL2; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Furans; Gene Expression Regulation; Humans; Inflammation; Kidney Tubules; Lignans; Membrane Glycoproteins; Microscopy, Fluorescence; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; NF-kappa B; Reactive Oxygen Species; Signal Transduction; Transforming Growth Factor beta1; Zonula Occludens-1 Protein | 2015 |
Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits type I-IV allergic inflammation and pro-inflammatory enzymes.
Topics: Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; B-Lymphocytes; Enzyme Inhibitors; Furans; Guinea Pigs; Hemagglutination; Histamine Antagonists; Histamine Release; Hypersensitivity; Inflammation; Lignans; Lung; Male; Mast Cells; Mice; Mice, Inbred BALB C; Rats; Rats, Sprague-Dawley; Skin; T-Lymphocytes | 2010 |
Arctigenin protects focal cerebral ischemia-reperfusion rats through inhibiting neuroinflammation.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Arctium; Furans; Infarction, Middle Cerebral Artery; Inflammation; Interleukin-1beta; Lignans; Macrophages; Male; Microglia; Neuroprotective Agents; Phytotherapy; Rats; Rats, Sprague-Dawley; Seeds; Tumor Necrosis Factor-alpha | 2012 |